The global Clarithromycin prices witnessed moderate upward movement during the fourth quarter of 2025, supported by tightening supply conditions, stable pharmaceutical demand, and increasing logistics costs in several regions. Clarithromycin, a widely used macrolide antibiotic, plays a crucial role in the treatment of respiratory infections, skin infections, and Helicobacter pylori-related diseases. As a result, its pricing dynamics are closely tied to the pharmaceutical manufacturing sector, raw material availability, and international trade flows.

During the quarter ending December 2025, the market remained relatively balanced across major regions including Asia-Pacific (APAC), Europe, and North America. While Asia maintained steady production levels, Western markets experienced stronger price growth due to restocking activities and higher freight costs. These factors collectively influenced the overall Clarithromycin price trend, resulting in mild price increases globally.

In particular, the global supply chain for pharmaceutical active ingredients remained stable compared to previous quarters, but fluctuations in shipping costs and regional inventory adjustments continued to impact the Clarithromycin market outlook.

Get Real time Prices for Clarithromycin : https://www.chemanalyst.com/Pricing-data/clarithromycin-1387

Clarithromycin Prices in APAC

China Clarithromycin Price Trend

In the Asia-Pacific region, China remained one of the largest producers and exporters of Clarithromycin during the fourth quarter of 2025. The Clarithromycin Price Index in China increased by 0.08% quarter-over-quarter, reflecting marginal export demand and consistent production levels across major manufacturing facilities.

The average Clarithromycin price in China was approximately USD 189,911.67 per metric ton, based on FOB Shanghai trade terms. Despite the modest price increase, the market remained largely stable due to balanced supply conditions and steady demand from international pharmaceutical manufacturers.

Chinese pharmaceutical producers maintained stable output levels throughout the quarter, supported by sufficient availability of raw materials such as erythromycin derivatives and fermentation intermediates. Additionally, the domestic pharmaceutical sector continued to operate at a consistent pace, which prevented significant fluctuations in the Clarithromycin price structure.

Another important factor influencing Clarithromycin prices in China was the export-oriented nature of the industry. Many international pharmaceutical companies rely on Chinese manufacturers for active pharmaceutical ingredients (APIs). However, export demand remained only slightly higher than the previous quarter, which limited the extent of price growth.

Logistics conditions also remained relatively stable in the region. Freight rates for shipments from China to Europe and North America experienced slight volatility but did not significantly disrupt export activities. As a result, Chinese Clarithromycin suppliers maintained competitive pricing in the global API market.

Overall, the APAC Clarithromycin market in Q4 2025 reflected stable production, marginal export growth, and balanced supply-demand dynamics, resulting in only a slight increase in prices.

Clarithromycin Prices in Europe

Germany Clarithromycin Price Trend

The European Clarithromycin market experienced stronger price growth compared to Asia during the fourth quarter of 2025. In Germany, the Clarithromycin Price Index rose by 3.09% quarter-over-quarter, indicating tighter supply conditions and active restocking among pharmaceutical distributors.

The average Clarithromycin price in Germany reached approximately USD 212,185.00 per metric ton, reported on CFR Hamburg trade terms. This price increase was mainly driven by higher import costs and inventory replenishment efforts by pharmaceutical companies.

European pharmaceutical manufacturers typically rely on imports of Clarithromycin APIs from Asia, particularly China and India. During the fourth quarter, limited shipment availability and slightly higher freight costs increased procurement expenses for European buyers. Consequently, distributors and pharmaceutical companies were forced to adjust their pricing strategies.

Another factor contributing to rising Clarithromycin prices in Europe was seasonal demand from the healthcare sector. Respiratory infections generally increase during colder months, which results in higher demand for antibiotics. Pharmaceutical companies and healthcare providers therefore increased inventory levels to ensure adequate supply for the winter season.

Furthermore, regulatory compliance costs in Europe also impacted Clarithromycin prices. Strict quality standards and regulatory requirements for pharmaceutical ingredients often lead to higher operational costs for importers and distributors. These costs were partially reflected in the market prices observed during the quarter.

In addition, currency fluctuations and international freight costs also played a role in shaping the European Clarithromycin market. While shipping conditions improved compared to earlier periods of global logistics disruption, transportation expenses remained relatively elevated, adding further pressure to pharmaceutical supply chains.

Overall, the Clarithromycin market in Europe during Q4 2025 was characterized by stronger restocking demand, tighter imports, and moderate cost pressures, leading to noticeable price growth in Germany and other European pharmaceutical hubs.

🌐 🔗 Track real time Clarithromycin Prices and market trends on ChemAnalyst: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Clarithromycin

Clarithromycin Prices in North America

United States Clarithromycin Price Trend

The North American Clarithromycin market, particularly in the United States, also experienced moderate price increases during the fourth quarter of 2025. The Clarithromycin Price Index in the USA rose by 3.10% quarter-over-quarter, reflecting tighter supply availability and increasing freight costs.

The average Clarithromycin price in the United States was approximately USD 212,205.00 per metric ton, reported on CFR basis. This price level was slightly higher than in Europe, indicating strong demand and logistical cost pressures in the North American pharmaceutical supply chain.

The U.S. pharmaceutical industry relies heavily on imported active pharmaceutical ingredients, including Clarithromycin. During Q4 2025, import shipments from Asia experienced minor delays and higher transportation costs, which contributed to rising procurement expenses for pharmaceutical manufacturers and distributors.

Another key driver of Clarithromycin price growth in the United States was inventory replenishment. Pharmaceutical companies increased purchasing activity toward the end of the year to maintain adequate stock levels for the upcoming quarters. This restocking trend placed additional pressure on supply availability and supported higher market prices.

Demand from the healthcare sector also remained stable throughout the quarter. Clarithromycin continues to be widely used in the treatment of respiratory tract infections, bronchitis, pneumonia, and other bacterial illnesses. Seasonal healthcare demand therefore contributed to steady consumption of this antibiotic across hospitals and pharmacies.

In addition, transportation costs within the United States remained relatively high during the quarter. Domestic freight rates and warehousing expenses increased operational costs for pharmaceutical distributors, which further influenced the Clarithromycin pricing structure.

Overall, the Clarithromycin market in North America during the fourth quarter of 2025 reflected tight supply conditions, consistent pharmaceutical demand, and rising logistics expenses, resulting in moderate price increases across the region.

Factors Influencing Clarithromycin Prices in Q4 2025

Several key factors influenced the Clarithromycin price trend globally during the quarter ending December 2025.

Pharmaceutical Demand

Clarithromycin remains an essential antibiotic used in the treatment of bacterial infections. Stable demand from hospitals, pharmacies, and pharmaceutical manufacturers ensured consistent market activity across all regions.

Supply Chain Conditions

Although global supply chains improved compared to earlier disruptions, minor logistics challenges and shipping costs continued to impact the movement of pharmaceutical ingredients.

Raw Material Availability

The production of Clarithromycin depends on fermentation processes and intermediates derived from erythromycin. Stable availability of these raw materials supported consistent production levels, particularly in Asia.

Freight and Logistics Costs

Freight costs and shipping delays played an important role in shaping price movements, especially in Europe and North America where Clarithromycin is primarily imported.

Seasonal Healthcare Demand

The winter season in Western regions typically increases demand for antibiotics due to higher rates of respiratory infections, which contributed to increased procurement activity during the quarter.

Global Clarithromycin Market Outlook

Looking ahead, the Clarithromycin price outlook remains cautiously stable with potential for mild fluctuations depending on supply chain conditions and pharmaceutical demand trends. Asia is expected to continue dominating production due to its established API manufacturing infrastructure and cost advantages.

However, Western markets such as Europe and North America may continue to experience slightly higher prices due to import dependency, regulatory costs, and transportation expenses.

If global logistics conditions improve further and raw material availability remains stable, Clarithromycin prices may stabilize in the coming quarters. Conversely, any disruptions in pharmaceutical supply chains or increased healthcare demand could result in additional upward price pressure.

Conclusion

In summary, Clarithromycin prices during the fourth quarter of 2025 showed moderate upward movement across major global markets. China experienced only a marginal increase due to stable production and limited export demand, while Europe and North America recorded stronger price growth driven by tighter imports, restocking activities, and rising freight costs.

With average prices reaching USD 189,911.67/MT in China, USD 212,185.00/MT in Germany, and USD 212,205.00/MT in the United States, the global Clarithromycin market demonstrated steady demand and relatively balanced supply conditions.

Moving forward, the Clarithromycin market will continue to be influenced by pharmaceutical industry demand, global trade flows, raw material availability, and logistics costs. These factors will play a key role in determining the future trajectory of Clarithromycin prices in the international pharmaceutical ingredients market.

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

ChemAnalyst

United States

Call +1 3322586602

420 Lexington Avenue, Suite 300, New York, NY,

United States, 10170

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_